527
Views
0
CrossRef citations to date
0
Altmetric
Bone-Mineral and Electrolyte Disorders

Predictive nomogram model for severe coronary artery calcification in end-stage kidney disease patients

, , , , , , , , , , , , & ORCID Icon show all
Article: 2365393 | Received 18 Jan 2024, Accepted 03 Jun 2024, Published online: 14 Jun 2024

References

  • Wen Y, Gan H, Li Z, et al. Safety of low-calcium dialysate and its effects on coronary artery calcification in patients undergoing maintenance hemodialysis. Sci Rep. 2018;8(1):1–12. doi:10.1038/s41598-018-24397-w.
  • Elhabashi AF, Sulaibeekh L, Seddiq N, et al. Presepsin level correlates with the development of moderate coronary artery calcifications in hemodialysis patients: a preliminary cross-section design study. Risk Manag Healthc Policy. 2020;13:999–1006. doi:10.2147/RMHP.S262058.
  • Jung C, Yun H, Park JT, et al. Association of coronary artery calcium with adverse cardiovascular outcomes and death in patients with chronic kidney disease: results from the know-ckd. Nephrol Dial Transpl. 2023;38(3):712–721. doi:10.1093/ndt/gfac194.
  • Iyer H, Abraham G, Reddy YNV, et al. Risk factors of chronic kidney disease influencing cardiac calcification. Saudi J Kidney Dis Transpl. 2013;24(6):1189–1194. doi:10.4103/1319-2442.121279.
  • Xie Q, Ge X, Shang D, et al. Coronary artery calcification score as a predictor of all-cause mortality and cardiovascular outcome in peritoneal dialysis patients. Perit Dial Int. 2016;36(2):163–170. doi:10.3747/pdi.2014.00124.
  • Seitun S, Clemente A, Maffei E, et al. Prognostic value of cardiac ct. Radiol Med. 2020;125(11):1135–1147. doi:10.1007/s11547-020-01285-w.
  • Blaha MJ, Budoff MJ, Defilippis AP, et al. Associations between c-reactive protein, coronary artery calcium, and cardiovascular events: implications for the jupiter population from mesa, a population-based cohort study. Lancet (London, England). 2011;378(9792):684–692. doi:10.1016/S0140-6736(11)60784-8.
  • Antonopoulos S, Mylonopoulou M, Angelidi AM, et al. Association of matrix γ-carboxyglutamic acid protein levels with insulin resistance and Lp(a) in diabetes: a cross-sectional study. Diabetes Res Clin Pract. 2017;130:252–257. doi:10.1016/j.diabres.2017.06.015.
  • Mathieu P, Boulanger M. Autotaxin and lipoprotein metabolism in calcific aortic valve disease. Front Cardiovasc Med. 2019;6:18. doi:10.3389/fcvm.2019.00018.
  • Ceponiene I, Li D, El KS, et al. Association of coronary calcium, carotid wall thickness, and carotid plaque progression with low-density lipoprotein and high-density lipoprotein particle concentration measured by ion mobility (from multiethnic study of atherosclerosis [mesa]). Am J Cardiol. 2021;142:52–58. doi:10.1016/j.amjcard.2020.11.026.
  • Peng J, Liu M, Liu H, et al. Lipoprotein (a)-mediated vascular calcification: population-based and in vitro studies. Metabolism. 2022;127:154960. doi:10.1016/j.metabol.2021.154960.
  • Mccullough PA. Effect of lipid modification on progression of coronary calcification. J Am Soc Nephrol. 2005;16 Suppl 2(11_suppl_2):S115–S119. doi:10.1681/ASN.2005060664.
  • Lee DY, Kim JH, Park SE, et al. Effects of low-density lipoprotein cholesterol on coronary artery calcification progression according to high-density lipoprotein cholesterol levels. Arch Med Res. 2017;48(3):284–291. doi:10.1016/j.arcmed.2017.06.005.
  • Stompór T, Pasowicz M, Sulłowicz W, et al. An association between coronary artery calcification score, lipid profile, and selected markers of chronic inflammation in esrd patients treated with peritoneal dialysis. Am J Kidney Dis. 2003;41(1):203–211. doi:10.1053/ajkd.2003.50005.
  • Shanahan CM, Crouthamel MH, Kapustin A, et al. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res. 2011;109(6):697–711. doi:10.1161/CIRCRESAHA.110.234914.
  • Raggi P, Chertow GM, Torres PU, et al. The advance study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin d on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant. 2011;26(4):1327–1339. doi:10.1093/ndt/gfq725.
  • Nishizawa Y, Mizuiri S, Yorioka N, et al. Determinants of coronary artery calcification in maintenance hemodialysis patients. J Artif Organs. 2015;18(3):251–256. doi:10.1007/s10047-015-0823-3.
  • Zhang H, Xiang S, Dai Z, et al. Asymmetric dimethylarginine level as biomarkers of cardiovascular or all-cause mortality in patients with chronic kidney disease: a meta-analysis. Biomarkers. 2021;26(7):579–585. doi:10.1080/1354750X.2021.1954694.
  • Pencak P, Czerwieńska B, Ficek R, et al. Calcification of coronary arteries and abdominal aorta in relation to traditional and novel risk factors of atherosclerosis in hemodialysis patients. BMC Nephrol. 2013;14(1):10. doi:10.1186/1471-2369-14-10.
  • Cui Y, Huang H, Ren W, et al. Parathyroidectomy is associated with reversed nondipping heart rate that impacts mortality in chronic kidney disease patients. Endocr Pract. 2022;28(2):148–158. doi:10.1016/j.eprac.2021.02.007.
  • Wang X, Yuan L, Shi R, et al. Predictors of coronary artery calcification and its association with cardiovascular events in patients with chronic kidney disease. Ren Fail. 2021;43(1):1172–1179. doi:10.1080/0886022X.2021.1953529.
  • Bellasi A, Di Lullo L, Russo D, et al. Predictive value of measures of vascular calcification burden and progression for risk of death in incident to dialysis patients. J Clin Med. 2021;10(3):376. doi:10.3390/jcm10030376.
  • Hwang Z, Suh KJ, Chen D, et al. Imaging features of soft-tissue calcifications and related diseases: a systematic approach. Korean J Radiol. 2018;19(6):1147. doi:10.3348/kjr.2018.19.6.1147.
  • Xiong L, Chen Q, Cheng Y, et al. The relationship between coronary artery calcification and bone metabolic markers in maintenance hemodialysis patients. BMC Nephrol. 2023;24(1):238. doi:10.1186/s12882-023-03286-z.
  • Chen J, Budoff MJ, Reilly MP, et al. Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease. JAMA Cardiol. 2017;2(6):635–643. doi:10.1001/jamacardio.2017.0363.
  • Matsuoka M, Iseki K, Tamashiro M, et al. Impact of high coronary artery calcification score (cacs) on survival in patients on chronic hemodialysis. Clin Exp Nephrol. 2004;8(1):54–58. doi:10.1007/s10157-003-0260-0.
  • Malluche HH, Blomquist G, Monier-Faugere M, et al. High parathyroid hormone level and osteoporosis predict progression of coronary artery calcification in patients on dialysis. J Am Soc Nephrol. 2015;26(10):2534–2544. doi:10.1681/ASN.2014070686.
  • Garland JS, Holden RM, Groome PA, et al. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 ckd without cardiovascular disease. Am J Kidney Dis. 2008;52(5):849–858. doi:10.1053/j.ajkd.2008.04.012.
  • Ge Y, Wu B, Yu X, et al. Association of serum sclerostin level, coronary artery calcification, and patient outcomes in maintenance dialysis patients. Blood Purif. 2022;51(3):260–269. doi:10.1159/000516410.
  • Han X, Cao Y, Ju Z, et al. Assessment of regional left ventricular myocardial strain in patients with left anterior descending coronary stenosis using computed tomography feature tracking. BMC Cardiovasc Disord. 2020;20(1):362. doi:10.1186/s12872-020-01644-5.
  • Blanke H, Cohen M, Schlueter GU, et al. Electrocardiographic and coronary arteriographic correlations during acute myocardial infarction. Am J Cardiol. 1984;54(3):249–255. doi:10.1016/0002-9149(84)90176-0.
  • Cozzolino M, Ciceri P, Galassi A, et al. The key role of phosphate on vascular calcification. Toxins (Basel). 2019;11(4):213. doi:10.3390/toxins11040213.
  • Shimizu M, Fujii H, Kono K, et al. Clinical implication of consistently strict phosphate control for coronary and valvular calcification in incident patients undergoing hemodialysis. J Atheroscler Thromb. 2023;30(11):1568–1579. doi:10.5551/jat.64159.
  • Panh L, Ruidavets JB, Rousseau H, et al. Association between serum alkaline phosphatase and coronary artery calcification in a sample of primary cardiovascular prevention patients. Atherosclerosis. 2017;260:81–86. doi:10.1016/j.atherosclerosis.2017.03.030.
  • Guo J, Zeng M, Zhang Y, et al. Serum alkaline phosphatase level predicts cardiac valve calcification in maintenance hemodialysis patients. Blood Purif. 2020;49(5):550–559. doi:10.1159/000505846.
  • Ishimura E, Okuno S, Okazaki H, et al. Significant association between bone-specific alkaline phosphatase and vascular calcification of the hand arteries in male hemodialysis patients. Kidney Blood Press Res. 2014;39(4):299–307. doi:10.1159/000355807.
  • Wu GY, Xu BD, Wu T, et al. Correlation between serum parathyroid hormone levels and coronary artery calcification in patients without renal failure. Biomed Rep. 2016;5(5):601–606. doi:10.3892/br.2016.761.
  • Hou Y, Liu W, Zheng C, et al. Role of vitamin d in uremic vascular calcification. Biomed Res Int. 2017;2017:2803579–2803513. doi:10.1155/2017/2803579.
  • Brahmbhatt S, Mikhail M, Islam S, et al. Vitamin d and abdominal aortic calcification in older african american women, the poda clinical trial. Nutrients. 2020;12(3):861. doi:10.3390/nu12030861.
  • Liu T, Zuo R, Wang J, et al. Association between serum 25-hydroxyvitamin d and abdominal aortic calcification: a large cross-sectional study. Int J Clin Pract. 2023;2023:1621873–1621810. doi:10.1155/2023/1621873.
  • Eddington H, Chinnadurai R, Alderson H, et al. A randomised controlled trial to examine the effects of cinacalcet on bone and cardiovascular parameters in haemodialysis patients with advanced secondary hyperparathyroidism. BMC Nephrol. 2021;22(1):106. doi:10.1186/s12882-021-02312-2.
  • Mediero A, Wilder T, Shah L, et al. Adenosine a(2a) receptor (a2ar) stimulation modulates expression of semaphorins 4d and 3a, regulators of bone homeostasis. Faseb J. 2018;32(7):3487–3501. doi:10.1096/fj.201700217R.
  • Wu Y, Zhang Q, Zhao B, et al. Effect and mechanism of propranolol on promoting osteogenic differentiation and early implant osseointegration. Int J Mol Med. 2021;48(4):1. doi:10.3892/ijmm.2021.5024.
  • Kong Y, Liang Q, Chen Y, et al. Hyaluronan negatively regulates vascular calcification involving bmp2 signaling. Lab Invest. 2018;98(10):1320–1332. doi:10.1038/s41374-018-0076-x.
  • Diederichsen SZ, Grønhøj MH, Mickley H, et al. Ct-detected growth of coronary artery calcification in asymptomatic middle-aged subjects and association with 15 biomarkers. JACC Cardiovasc Imaging. 2017;10(8):858–866. doi:10.1016/j.jcmg.2017.05.010.
  • Cardoso R, Generoso G, Staniak HL, et al. Predictors of coronary artery calcium incidence and progression: the brazilian longitudinal study of adult health (elsa-brasil). Atherosclerosis. 2020;309:8–15. doi:10.1016/j.atherosclerosis.2020.07.003.
  • Generoso G, Bensenor IM, Santos RD, et al. High-density lipoprotein-cholesterol subfractions and coronary artery calcium: the elsa-brasil study. Arch Med Res. 2019;50(6):362–367. doi:10.1016/j.arcmed.2019.10.006.
  • Seyahi N, Cebi D, Altiparmak MR, et al. Progression of coronary artery calcification in renal transplant recipients. Nephrol Dial Transplant. 2012;27(5):2101–2107. doi:10.1093/ndt/gfr558.
  • Xu C, Smith ER, Tiong MK, et al. Interventions to attenuate vascular calcification progression in chronic kidney disease: a systematic review of clinical trials. J Am Soc Nephrol. 2022;33(5):1011–1032. doi:10.1681/ASN.2021101327.
  • Wen W, Portales-Castillo I, Seethapathy R, et al. Intravenous sodium thiosulphate for vascular calcification of hemodialysis patients—a systematic review and meta-analysis. Nephrol Dial Transplant. 2023;38(3):733–745. doi:10.1093/ndt/gfac171.
  • Vermeulen EA, Vervloet MG. Magnesium administration in chronic kidney disease. Nutrients. 2023;15(3):547. doi:10.3390/nu15030547.
  • Pan W, Jie W, Huang H. Vascular calcification: molecular mechanisms and therapeutic interventions. MedComm (2020). 2023;4(1):e200. doi:10.1002/mco2.200.
  • Vaziri ND, Norris KC. Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations. Blood Purif. 2013;35(1-3):31–36. doi:10.1159/000345176.
  • Chen Z, Qureshi AR, Parini P, et al. Does statins promote vascular calcification in chronic kidney disease? Eur J Clin Invest. 2017;47(2):137–148. doi:10.1111/eci.12718.
  • Nakagami H, Osako MK, Morishita R. New concept of vascular calcification and metabolism. Curr Vasc Pharmacol. 2011;9(1):124–127. doi:10.2174/157016111793744742.
  • Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (study of heart and renal protection): a randomised placebo-controlled trial. Lancet. 2011;377(9784):2181–2192. doi:10.1016/S0140-6736(11)60739-3.
  • Miyazaki Anzai S, Masuda M, Demos Davies KM, et al. Endoplasmic reticulum stress effector ccaat/enhancer-binding protein homologous protein (CHOP) regulates chronic kidney disease–induced vascular calcification. J Am Heart Assoc. 2014;3(3):e000949. doi:10.1161/JAHA.114.000949.
  • Tacey A, Qaradakhi T, Brennan-Speranza T, et al. Potential role for osteocalcin in the development of atherosclerosis and blood vessel disease. Nutrients. 2018;10(10):1426. doi:10.3390/nu10101426.
  • Kuzan A, Chwiłkowska A, Maksymowicz K, et al. Relationships between osteopontin, osteoprotegerin, and other extracellular matrix proteins in calcifying arteries. Biomedicines. 2024;12(4):847. doi:10.3390/biomedicines12040847.
  • Tang X, Qian H, Zeng M, et al. Predictive model for severe coronary artery calcification in ESKD patients. medRxiv [Preprint]. doi:10.1101/2023.12.16.23300066.